← Eichor
Study identifier: NCT06482749 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Repetitive Transcranial Magnetic Stimulation and Postoperative Neurocognitive Recovery

Condition: Older Patients · Cognitive Impairment · Repetitive Transcranial Magnetic Stimulation  ·  Sponsor: Peking University First Hospital

PhaseNA
Planned participants568
Who can joinAll sexes, 65 Years to no upper limit
Healthy volunteersNo

About this study

Patients with preoperative cognitive impairment are at increased risks of delayed neurocognitive recovery (DNR) and postoperative neurocognitive disorder (POCD). Repetitive transcranial magnetic stimulation (rTMS) has been used to improve cognitive function in patients with cognitive impairement. This trial is designed to compare the effects of rTMS versus sham intervention on postoperative neurocognitive function in patients with preoperative cognitive impairment.

This description comes directly from the study's public registry record.

Talk to the study team

Dong-Xin Wang, MD, PhD  ·  8610 83572784  ·  wangdongxin@hotmail.com

Hao Kong, MD  ·  8610 83575138  ·  konghao2438@126.com

Always discuss trial participation with your own doctor first.

Locations (3)

Peking University First HospitalBeijing, Beijing Municipality, ChinaRecruiting
Peking University Shenzhen HospitalShenzhen, Guangzhou, ChinaNot Yet Recruiting
Xijing Hospital, Air Force Medical UniversityXi'an, Shannxi, ChinaNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06482749